Capital Planning Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.89M Sell
11,842
-124
-1% -$28.9K 0.42% 44
2025
Q4
$2.48M Buy
11,966
+534
+5% +$106K 0.33% 56
2025
Q3
$2.12M Sell
11,432
-851
-7% -$146K 0.29% 58
2025
Q2
$1.88M Sell
12,283
-1,541
-11% -$237K 0.28% 59
2025
Q1
$2.29M Sell
13,824
-1,586
-10% -$248K 0.35% 56
2024
Q4
$2.23M Sell
15,410
-10,123
-40% -$1.57M 0.34% 57
2024
Q3
$4.14M Sell
25,533
-5,261
-17% -$838K 0.62% 43
2024
Q2
$4.5M Sell
30,794
-3,044
-9% -$453K 0.77% 35
2024
Q1
$5.35M Sell
33,838
-236
-0.7% -$37.6K 0.94% 29
2023
Q4
$5.34M Sell
34,074
-2,789
-8% -$428K 1.01% 23
2023
Q3
$5.74M Sell
36,863
-279
-0.8% -$46K 1.2% 22
2023
Q2
$6.15M Sell
37,142
-342
-0.9% -$55.2K 1.25% 21
2023
Q1
$5.81M Sell
37,484
-1,479
-4% -$239K 1.23% 23
2022
Q4
$6.88M Buy
38,963
+3,209
+9% +$554K 1.64% 15
2022
Q3
$5.84M Buy
35,754
+2,625
+8% +$444K 1.57% 19
2022
Q2
$5.88M Buy
33,129
+681
+2% +$121K 1.56% 21
2022
Q1
$5.75M Buy
32,448
+253
+0.8% +$43K 1.23% 23
2021
Q4
$5.51M Buy
32,195
+510
+2% +$83.5K 1.05% 26
2021
Q3
$5.12M Sell
31,685
-626
-2% -$107K 1.06% 25
2021
Q2
$5.32M Sell
32,311
-453
-1% -$75K 1.09% 25
2021
Q1
$5.38M Sell
32,764
-3,808
-10% -$616K 1.21% 24
2020
Q4
$5.76M Sell
36,572
-1,605
-4% -$237K 1.41% 21
2020
Q3
$5.68M Sell
38,177
-347
-0.9% -$51.3K 1.56% 19
2020
Q2
$5.42M Buy
38,524
+1,004
+3% +$146K 1.61% 15
2020
Q1
$4.92M Buy
37,520
+11
+0% +$1.56K 1.84% 12
2019
Q4
$5.47M Buy
37,509
+726
+2% +$98.5K 1.43% 17
2019
Q3
$4.76M Sell
36,783
-3,700
-9% -$487K 1.39% 19
2019
Q2
$5.64M Sell
40,483
-734
-2% -$102K 1.66% 14
2019
Q1
$5.76M Sell
41,217
-1,833
-4% -$246K 1.76% 15
2018
Q4
$5.56M Buy
43,050
+368
+0.9% +$51.3K 2.02% 11
2018
Q3
$5.9M Buy
42,682
+15,904
+59% +$2.11M 1.88% 12
2018
Q2
$3.25M Sell
26,778
-16,451
-38% -$2.05M 1.47% 13
2018
Q1
$5.54M Sell
43,229
-331
-0.8% -$44.7K 1.97% 11
2017
Q4
$6.09M Buy
43,560
+983
+2% +$137K 2.14% 9
2017
Q3
$5.54M Buy
42,577
+1,260
+3% +$167K 2.17% 9
2017
Q2
$5.47M Sell
41,317
-4,200
-9% -$536K 2.42% 7
2017
Q1
$5.67M Sell
45,517
-4,375
-9% -$523K 2.8% 7
2016
Q4
$5.75M Sell
49,892
-3,828
-7% -$442K 3.07% 6
2016
Q3
$6.35M Sell
53,720
-560
-1% -$67.9K 3.39% 5
2016
Q2
$6.58M Buy
54,280
+641
+1% +$72.8K 3.66% 4
2016
Q1
$5.8M Buy
53,639
+1,941
+4% +$201K 2.79% 5
2015
Q4
$5.31M Buy
51,698
+6,781
+15% +$682K 3.09% 5
2015
Q3
$4.19M Buy
44,917
+2,780
+7% +$269K 2.75% 5
2015
Q2
$4.11M Buy
42,137
+4,525
+12% +$453K 2.41% 5
2015
Q1
$3.78M Buy
37,612
+3,275
+10% +$333K 2.64% 6
2014
Q4
$3.59M Buy
+34,337
New +$3.62M 3.12% 5

Other funds holding JNJ

Capital Planning Advisors's JNJ Position: Q1 2026 in Review

Capital Planning Advisors reduced its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, selling an estimated $28.9K and leaving 11,842 shares worth $2.89M. The position accounts for 0.42% of the portfolio, ranked #44.

Capital Planning Advisors first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.88M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Planning Advisors held 11,842 shares of Johnson & Johnson worth $2.89M as of Q1 2026.
  • Capital Planning Advisors sold 124 Johnson & Johnson shares in Q1 2026, an estimated $28.9K.
  • Johnson & Johnson made up 0.42% of Capital Planning Advisors's portfolio in Q1 2026, its #44 holding.
  • Capital Planning Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • Capital Planning Advisors's Johnson & Johnson position peaked at $6.88M in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Planning Advisors's 13F filing for Q1 2026, filed 14 May 2026.